MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Transcranial Magnetic Stimulation as Treatment for Functional Movement Disorders: Experiences from a Single Centre Retrospective Audit

    I. Osborne, J. Peters, S. Tisch (Darlinghurst, Australia)

    Objective: St Vincent’s Hospital Sydney has been offering Transcranial Magnetic Stimulation (TMS) to adult patients with a diagnosis of Functional Movement Disorders (FMD) since 2020.…
  • 2025 International Congress

    Tourette – Like Phenotypes Following Combined Striatal Interneuron Loss.

    C. Coll, J. Beccaria, B. Braz, A. Lopez Diaz, J. Belforte, M. Murer (Buenos Aires, Argentina)

    Objective: To determine whether the ablation of Nkx2.1 derived striatal interneurons (SI) in mice produces Tourette-like phenotypes including abnormal movements and perseverative behaviors. Background: Tourette…
  • 2025 International Congress

    Neuroprotective Effects of Co-Administered Hesperetin and Resveratrol Nanoparticles on Oxidative Stress and Neurobehavioral Deficits in Parkinson’s Disease

    R. Rajput, S. Verma (Agra, India)

    Objective: This study aimed to evaluate the therapeutic potential of solid lipid nanoparticles (SLNs) containing hesperetin (HE-SLN), resveratrol (RE-SLN), and their co-administration (HE-RE-SLN) in combating…
  • 2025 International Congress

    SREAT with Cerebellar Involvement: When Tremor Mimics Stroke – A Case report

    S. Camargo-Casas, N. Rueda, S. Preciado, X. Garcia (Bogota, Colombia)

    Objective: To describe a patient with SREAT in whom an initial diagnosis of a stroke was made Background: Acute ataxia is a clinical setting where…
  • 2025 International Congress

    Artificial Intelligence in the Early Detection of Parkinson’s Disease: Advances, Challenges, and Future Perspectives

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: This study reviews AI’s role in early PD detection, comparing AI-driven diagnostic methods with conventional clinical approaches in accuracy, reliability, and applicability. Background: Parkinson’s…
  • 2025 International Congress

    Deep Learning-Driven Discovery of Mitochondrial Genomic Instability in Parkinson’s Disease: A Single-Cell Multi-Omics Approach

    R. Fajar, A. Ureng (Sleman, Indonesia)

    Objective: This study integrates snRNA-seq and proteomic data to (i) map mtDNA heteroplasmic mutations at single-cell resolution, (ii) identify mitochondrial-driven transcriptional dysregulation, and (iii) classify…
  • 2025 International Congress

    Neurodegenerative Langerhans Cell Histiocytosis: A Rare Cause of Cerebellar Ataxia

    C. Onuigbo, S. Pradeep (Houston, USA)

    Objective: To describe a rare case of progressive cerebellar ataxia due to neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) and highlight diagnostic challenges with atypical imaging findings.…
  • 2025 International Congress

    Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses

    D. Ghosh, P. Basu, S. Mondal, S. Pal (Kolkata, India)

    Objective: This large-scale case-control study using network pharmacology and molecular docking, aimed to identify dietary and environmental risk factors of Parkinson’s disease (PD). Background: PD…
  • 2025 International Congress

    Challenges in the Diagnosis and Management of Functional Movement Disorders in a Developing Nation: Insights from the Philippines

    KA. Pañares, A. Lang, G. Saranza (Cebu, Philippines)

    Objective: To systematically analyze patient data to explore the clinical phenotypes, risk factors, management, and outcomes among patients with functional movement disorders (FMD) in  the…
  • 2025 International Congress

    Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

    RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)

    Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley